×
Health / Pharamceutical

Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine

Published Jul 22 2020 at 9:03 AM GMT
Drugs.com

Drugs.com @drugs.com

Continue reading at drugs.com
Key
Points
  • Audience: Consumer, Health Professional, Pharmacy July 22, 2020 -- Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0 9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial.
Credit
Tags
Continue reading at drugs.com
Trending

Stats

  • Published Jul 22, 2020 9:03 AM GMT